Trial Profile

Multiple-dose trial of EVT 201 in China

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 21 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dimdazenil (Primary)
Indications Insomnia
Focus Adverse reactions
Sponsors Zhejiang Jingxin Pharmaceutical

Most Recent Events

30 Mar 2015 New trial record
24 Mar 2015 This multiple-dose study was initiated in 2014 by JingXin Pharmaceutical, according to an Evotec media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com